Greg Garland - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Independent Director

Mr. Greg C. Garland is an Independent Director of Amgen Inc. Mr. Garland is the Chairman President and Chief Executive Officer of Phillips 66 an energy manufacturing and logistics company with midstream chemical refining and marketing and specialties businesses created through the repositioning of ConocoPhillips having held this position since April 2012. Mr. Garland chairs the Executive Committee of Phillips 66. Prior to Phillips 66 Mr. Garland served as Senior Vice President Exploration and Production Americas of ConocoPhillips from 2010 to April 2012. He was President and Chief Executive Officer of Chevron Phillips Chemical Company from 2008 to 2010 and Senior Vice President Planning and Specialty Chemicals from 2000 to 2008. Mr. Garland served in various positions at Phillips Petroleum Company from 1980 to 2000. Mr. Garland is a member of the Engineering Advisory Board for Texas AM University.
Age: 56  Director Since 2013      
805 447-1010  www.amgen.com

Greg Garland Latest Insider Activity

Greg Garland over three months ago via Macroaxis 
Phillips 66 exotic insider transaction detected
Greg Garland over three months ago via Macroaxis 
Phillips 66 exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Ronald RittenmeyerQuintiles IMS Holdings Inc
2016
Ronald TaylorAllergan plc
2013
Mireille GillingsQuintiles IMS Holdings Inc
2013
Phebe NovakovicAbbott Laboratories
2010
Robert AlpernAbbott Laboratories
2008
Michael GallagherAllergan plc
2015
Jonathan CosletQuintiles IMS Holdings Inc
2003
William OsbornAbbott Laboratories
2013
Leonard SchaefferQuintiles IMS Holdings Inc
2008
Sally BlountAbbott Laboratories
2011
David AltshulerVertex Pharmaceuticals Incorpor
2015
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Roxanne AustinAbbott Laboratories
2000
Michael HyattEndo International plc
N/A
David GreenwayVertex Pharmaceuticals Incorpor
2017
John ConnaughtonQuintiles IMS Holdings Inc
2008
Christopher BodineAllergan plc
2013
Douglas IngramEndo International plc
2016
Fred CohenQuintiles IMS Holdings Inc
2007
Edward LiddyAbbott Laboratories
2010

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators